Long-Term Safety, Clinical and Immunological Outcomes in Primary Membranous Nephropathy with Severe Renal Impairment Treated with Cyclophosphamide and Steroid-Based Regimen

INTRODUCTION AND AIMS: Therapy of primary membranous nephropathy (PMN) with progressive advanced kidney dysfunction is challenging with limited literature and no clear therapeutic strategies. This is due to the scant evidence of effectiveness and uncertainty around the risk-benefit profile of immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Ragy, Omar, Hamilton, Patrick, Pathi, Anjali, Ahmed, Adil Abdalla Mohamed, Mitra, Sandip, Kanigicherla, Durga A.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126738/
https://www.ncbi.nlm.nih.gov/pubmed/37113496
http://dx.doi.org/10.1159/000529605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126738/
https://www.ncbi.nlm.nih.gov/pubmed/37113496
http://dx.doi.org/10.1159/000529605

Ejemplares similares